Literature DB >> 33022705

Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study.

Daehoon Kim1, Pil-Sung Yang2, Jung-Hoon Sung2, Eunsun Jang1, Hee Tae Yu1, Tae-Hoon Kim1, Jae-Sun Uhm1, Jong-Youn Kim1, Hui-Nam Pak1, Moon-Hyoung Lee1, Gregory Y H Lip3, Boyoung Joung1.   

Abstract

AIMS: Accumulating evidence shows that atrial fibrillation (AF) is associated with an increased risk of dementia. Catheter ablation for AF prolongs the duration of sinus rhythm, thereby improving the quality of life. We investigated the association of catheter ablation for AF with the occurrence of dementia. METHODS AND
RESULTS: Using the Korean National Health Insurance Service database, among 194 928 adults with AF treated with ablation or medical therapy (antiarrhythmic or rate control drugs) between 1 January 2005 and 31 December 2015, we studied 9119 patients undergoing ablation and 17 978 patients managed with medical therapy. The time-at-risk was counted from the first medical therapy, and ablation was analysed as a time-varying exposure. Propensity score-matching was used to correct for differences between the groups. During a median follow-up of 52 months, compared with patients with medical therapy, ablated patients showed lower incidence and risk of overall dementia (8.1 and 5.6 per 1000 person-years, respectively; hazard ratio 0.73, 95% confidence interval 0.58-0.93). The associations between ablation and dementia risk were consistently observed after additionally censoring for incident stroke (hazard ratio 0.76, 95% confidence interval 0.61-0.95) and more pronounced in cases of ablation success whereas no significant differences observed in cases of ablation failure. Ablation was associated with lower risks of dementia subtypes including Alzheimer's disease and vascular dementia.
CONCLUSION: In this nationwide cohort of AF patients treated with catheter ablation or medical therapy, ablation was associated with decreased dementia risk. This relationship was evident after censoring for stroke and adjusting for clinical confounders. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Dementia

Mesh:

Year:  2020        PMID: 33022705     DOI: 10.1093/eurheartj/ehaa726

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  24 in total

1.  The myocardial flow reserve in patients with heart failure with preserved ejection fraction.

Authors:  Andrew V Mochula; Kristina V Kopeva; Alina N Maltseva; Elena V Grakova; Marina Gulya; Andrey V Smorgon; Anna Gusakova; Konstantin V Zavadovsky
Journal:  Heart Vessels       Date:  2022-09-01       Impact factor: 1.814

2.  PRRX1 Loss-of-Function Mutations Underlying Familial Atrial Fibrillation.

Authors:  Xiao-Juan Guo; Xing-Biao Qiu; Jun Wang; Yu-Han Guo; Chen-Xi Yang; Li Li; Ri-Feng Gao; Zun-Ping Ke; Ruo-Min Di; Yu-Min Sun; Ying-Jia Xu; Yi-Qing Yang
Journal:  J Am Heart Assoc       Date:  2021-11-30       Impact factor: 6.106

Review 3.  [The ESC recommendations for COVID-19-no guideline, but a learning guidance].

Authors:  Bernhard Maisch
Journal:  Herz       Date:  2020-12-14       Impact factor: 1.443

Review 4.  Heart and brain interactions : Pathophysiology and management of cardio-psycho-neurological disorders.

Authors:  Renate B Schnabel; Gert Hasenfuß; Sylvia Buchmann; Kai G Kahl; Stefanie Aeschbacher; Stefan Osswald; Christiane E Angermann
Journal:  Herz       Date:  2021-02-05       Impact factor: 1.443

Review 5.  Prevention of Dementia in Patients with Atrial Fibrillation.

Authors:  Daehoon Kim; Pil Sung Yang; Boyoung Joung
Journal:  Korean Circ J       Date:  2021-04       Impact factor: 3.243

6.  Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.

Authors:  Daehoon Kim; Pil-Sung Yang; Seng Chan You; Jung-Hoon Sung; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  BMJ       Date:  2021-05-11

Review 7.  Impact of Catheter Ablation on Stroke, Cognitive Decline and Dementia.

Authors:  Tyson S Burnham; Monte L Scott; Benjamin A Steinberg; Daniel L Varela; Brian Zenger; T Jared Bunch
Journal:  Arrhythm Electrophysiol Rev       Date:  2021-10

8.  Cerebral Microbleeds With Atrial Fibrillation After Ablation Therapy.

Authors:  Yoshinori Hirata; Natsuko Kato; Kanako Muraga; Akihiro Shindo; Naoko Nakamura; Keita Matsuura; Yuichiro Ii; Mariko Shiga; Ken-Ichi Tabei; Masayuki Satoh; Tomoyuki Fukuma; Yoshihiko Kagawa; Satoshi Fujita; Ryota Kogue; Maki Umino; Masayuki Maeda; Hajime Sakuma; Kaoru Dohi; Hidekazu Tomimoto
Journal:  Front Cell Neurosci       Date:  2022-02-14       Impact factor: 5.505

Review 9.  Role of advanced imaging in COVID-19 cardiovascular complications.

Authors:  Federica Catapano; Livia Marchitelli; Giulia Cundari; Francesco Cilia; Giuseppe Mancuso; Giacomo Pambianchi; Nicola Galea; Paolo Ricci; Carlo Catalano; Marco Francone
Journal:  Insights Imaging       Date:  2021-02-24

Review 10.  Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines.

Authors:  M Cristina Polidori; Mariana Alves; Gulistan Bahat; Anne Sophie Boureau; Serdar Ozkok; Roman Pfister; Alberto Pilotto; Nicola Veronese; Mario Bo
Journal:  Eur Geriatr Med       Date:  2021-11-02       Impact factor: 1.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.